Insiders · Profile

Hudson Leslie

Former CEO at Sarepta Therapeutics. Filing since 24 Mar 2010. CIK 0001321265

Company
Date
Role
Action
Shares
Amount
Of holding
30 Jul 2010
Former CEO
Sold, plan not stated
183,486
$354.11K
32.3%
28 Jul 2010
Former CEO
Sold, plan not stated
183,486
$334.37K
32.3%
26 Jul 2010
Former CEO
Sold, plan not stated
129,083
$245.90K
25.1%
23 Jul 2010
Former CEO
Sold, plan not stated
205,400
$369.72K
34.8%
22 Jul 2010
Former CEO
Sold, plan not stated
265,517
$477.51K
40.8%
16 Jul 2010
Former CEO
Sold, plan not stated
100,028
$188.11K
20.6%
9 Jul 2010
Former CEO
Sold, plan not stated
200,000
$316.13K
34.2%
7 Jul 2010
Former CEO
Sold, plan not stated
200,000
$292.02K
34.2%
6 Jul 2010
Former CEO
Sold, plan not stated
21,089
$32.46K
5.2%
2 Jul 2010
Former CEO
Sold, plan not stated
128,911
$201.42K
25.1%
24 Jun 2010
Former CEO
Sold, plan not stated
51,338
$63.66K
11.8%
24 Mar 2010
Former CEO
Sold, plan not stated
21,427
$31.93K
4.7%
12 decisions on file.